Cannabis finance news

Cann Global applies to extend trading halt again as it pursues ‘major’ acquisition opportunity

by Martin Lane September 18, 2023April 30, 2024

Cann Global (CGB) has requested another extension to its voluntary ASX trading halt as it concludes […]

Cannabis executive salaries: who earned what in FY23

by Steve Jones September 13, 2023September 14, 2023

Emyria completes acquisition of Pax Centre for A$1.7m

by Martin Lane September 13, 2023April 30, 2024

Medlab updates shareholders on ‘proposed restructure’

by Martin Lane September 12, 2023April 30, 2024

Financial results: Avecho; Wellnex; Zelira; Emyria; Botanix; MGC Pharma; AusCann; Epsilon; Melodiol; Bioxyne

by Martin Lane and Steve Jones September 4, 2023April 30, 2024

Althea reports record sales from Australian arm

by Martin Lane September 1, 2023April 30, 2024

ECS Botanics reports record revenue and positive EBITDA for FY23

by Martin Lane August 31, 2023April 30, 2024

Judge us on the future, not the past, says Cann Group CEO amid calls to view annual report ‘in context’

by Steve Jones August 30, 2023August 31, 2023

Company news: Rua Bioscience; IDT Australia; Emyria; Elixinol Wellness; Neurotech; Hygrovest; Releaf Group/ICCM; Botanix

by Martin Lane August 30, 2023April 30, 2024

Bod Science eyes new revenue streams after reporting heavy loss

by Steve Jones August 30, 2023August 30, 2023